Sec Form 4 Filing - Mehdizadeh P Vincent @ Medbox, Inc. - 2014-06-05

FORM 4 Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0287 Expires: November 30, 2011 Estimated average burden hours per response... 0.5

1. Name and Address of Reporting Person Mehdizadeh P Vincent 2. Issuer Name and Ticker or Trading Symbol Medbox, Inc. [ MDBX] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) _____ Director X __ 10% Owner X __ Officer (give title below) _____ Other (specify below) Founder, Senior Strategist (Last) (First) (Middle) 8439 W. SUNSET BLVD., SUITE 101 3. Date of Earliest Transaction (MM/DD/YY) 06/05/2014 (Street) WEST HOLLYWOOD, CA90069 4. If Amendment, Date Original Filed (MM/DD/YY) 6. Individual or Joint/Group Filing (Check Applicable Line) __ X __ Form filed by One Reporting Person _____ Form filed by More than One Reporting Person (City) (State) (Zip)
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned 1.Title of Security (Instr. 3) 2. Transaction Date (MM/DD/YY) 2A. Deemed Execution Date, if any (MM/DD/YY) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4) Code V Amount (A) or (D) Price Common Stock 06/05/2014 J( 1 ) 60,000 D 16,178,940 I See Note ( 2 ) Common Stock 06/13/2014 S( 4 ) 68,385 D $ 7 16,110,555 I See Note ( 3 )
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities) 1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (MM/DD/YY) 3A. Deemed Execution Date, if any (MM/DD/YY) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4, and 5) 6. Date Exercisable and Expiration Date (MM/DD/YY) 7. Title and Amount of Underlying Securities (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4) Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Reporting Owners Reporting Owner Name / Address Relationships Director 10% Owner Officer Other Mehdizadeh P Vincent 8439 W. SUNSET BLVD. SUITE 101 WEST HOLLYWOOD, CA90069 X Founder, Senior Strategist	Signatures /s/ Vincent Mehdizadeh 06/13/2014 Signature of Reporting Person Date

Explanation of Responses:

( 1 )PMV International, Inc. returned 30,000 shares to the Issuer in exchange for the Issuer's rights and claims attributable to or controlled by the Issuer as a result of the Issuer's transactions with Bio Tech Medical Software, Inc., and returned 30,000 shares to the Issuer in exchange for the Issuer's rights and claims attributable to or controlled by the Issuer as a result of the Issuer's transactions with those three certain stockholders of Medvend, Inc. known as Kaplan, Tartaglia and Kovan. ( 2 )Following this transaction, 13,036,302 shares were held by Vincent Chase, Inc. and 3,142,638 shares were held by PVM International, Inc., each of which are owned and controlled by the Reporting Person. ( 3 )13,036,302 shares are held by Vincent Chase, Inc. and 3,074,253 shares are held by PVM International, Inc., each of which are owned and controlled by the Reporting Person. ( 4 )PVM International, Inc. sold 68,385 shares of restricted stock to existing accredited investor shareholders of Medbox, Inc. This sale occurred for the seller to engage in tax planning activities.

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4(b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.